The aim of this mini-review is to show the usefulness of pteridines as clinical markers. We assayed urinary neopterin and xanthopterin levels in liver disease. Total pterins were oxidized by active carbon to yield xanthopterin. Urinary neopterin levels were elevated in patients with chronic active hepatitis and in those with chronic persistent hepatitis but not in patients with alcohol-induced liver disease or in those with non-alcoholic fatty liver. Urinary xanthopterin levels were elevated in chronic active hepatitis and alcohol-induced liver disease, but not in chronic persistent hepatitis and non-alcoholic fatty liver. Urinary neopterin levels were high in infectious diseases involving activated cell-mediated immunity, and increased urinary xanthopterin reflects liver-cell damage.
Introduction
Because pteridines were first found in insects, many studies on the biological aspects of these compounds were carried out using insects. Around the middle of this century, as a consequence of an increasing interest in genetics, many scientists began studying the relationship between eye color compounds and pterins together with ommochrome from mutants of Drosophila melanogaster. These in- § Author to whom correspondence should be addressed .
Pteridines/ Vol. 7 / No. 4 vestigations were carried out for nearly two decades. Pteridines also have a role in determining the body color of insects. Sepiapterin reductase (EC 1.1.1. 153), which has an important role in the synthesis of pteridine cofactor, was first found in the silkworm as a characteristic deficiency of this enzyme results in mutant lemon ( 1) . Color substances in the larval silkworm are determined by pteridines, ommochrome and melanin (2) . Among these compounds, the amounts of xanthommatin are under juvenile hormone control (3) . The scorpion fly, Panorpa japonica, shows seasonal color di-morphism and the yellow body color substance is due to sepiapterin (4) .
These color substances are usually localized in cytosol granules. In epidermal cells of the mutant lemon silkworm, sepiapterin, sepialumazine and sepiapterin deaminase (EC 3.5.4.24) are localized in granules together with uric acid ( 5). On-the other hand, xanthommatin is located in different granules, in the same tissue, combined with protein (6) .
Among the pteridine derivatives, tetrahydrobiopterin plays a very important physiological role . Tetrahydrobiopterin is a cofactor for the monooxygenases which catalyze hydroxylation of aromatic amino acids (7) . In contrast to classical phenylketonuria, deficiency of tetrahydro-biopterin has been designated an atypical phenylketonuria (8, 9) . On the other hand, the importance of urinary neopterin levels as clinical markers was suggested by Wachter and colleagues. Urinary and serum neopterin concentrations are elevated in the setting of infection or malignant dis-orders with activated cellmediated immunity (10) (11) (12) . In 1987, Prior et al. ( 13) reported that urinary neopterin values have been utilized to distinguish between chronic non-A, non-B hepatitis and liver steatosis. At that time, all blood at the Japanese Red Cross had been screened for alanine aminotransferase (ALT) values as a means of preventing post-transfusion hepatitis type non-A, non-B (PTHNANB) . However, PTHNANB still occurred at an incidence rate of 10-20% in patients receiving transfusion therapy (14) (15) (16) . Based on the necessity of screening blood samples for transfusion, we have endeavored to assay urinary pteridines.
Because pteridine metabolism takes place mainly in the liver (17) , the excretion of other pteridine derivatives, besides neopterin, may serve as an indicator of liver disease. Fukushima et al. (18) have described the existence of numerous urinary pteridines. Some of these compounds are in dihydro-form. Therefore, we assayed both neopterin and total pterin as xanthopterin. Little information is available on urinary xanthopterin ( 19, 20 ) . As a consequence of sequential investigations, we realized that pteridines were a sensitive and valuable marker, with several potential clinical uses. In the present report, we summarize our efforts in this area of research.
Pteridine determination
In the 1980s, neopterin was determined after oxidation. Therefore , we measured the amount of urinary neopterin after acidic iodine oxidation and the application of an HPLC system, utilizing the method of Yoshioka et al. (21) . Fuchs et al. (22) reported a high correlation between urinary neopterin, regardless of oxidation, and dihydroneopterin decomposed to pterins other than neopterin. Subsequently, we directly assayed neopterin using a RIA kit "IMMU test neopterin" (Henning Berlin GmbH, Berlin, Germany) without oxidation.
As a trial, urinary xanthopterin was measured applying the isolation method of Plesner and Karckar (23) and using HPLC for quantification, as follows: To 6 mg of activated charcoal (Norit A or Norit SX-3) 10 ~l of 1 M acetic acid and 1 ml of urine were added successively, then mixed, and allowed to stand in darkness for 10 minutes . The mixture was centrifuged at 6,700 g for 5 minutes. The resulting precipitate was washed with distilled water, then resuspended in 500 ~I of 0.05 M NaOH contain-ing 20% pyridine. This mixture was centrifuged at 6,700 g for 5 min and, after 10 fold dilution of the supernatant with distilled water, 50 ~l of the solution were injected into the HPLC system (24 ) . This method is anticipated to be applicable in small hospitals or institutes where only a centrifuge and fluorometer are available. An Asahipack GS 320 H (Asahi Chemical Industry Co., Ltd., Kawasaki, Japan) was used as the column . Fluorometry was carried out at an excitation wavelength of 390 nm and emission wavelength of 460 nm with a cut off filter shorter than 460 nm. The mobile phase was 10% methanol containing 10 mM potassium phosphate buffer, pH 7.0, at a flow rate of 1 mljminute. Under these conditions, xanthopterin constituted the main peak and its retention time was approximately 10.5 minutes.
Liver disease and urinary pteridines
We assayed urinary neopterin, biopterin and xanthopterin levels in patients with chronic non-A, non-B hepatitis and in patients with fatty liver disease (24 ) . Urinary neopterin levels were elevated in patients with chronic non-A, non-B hepatitis, but did not in patients with fatty liver, in accordance with the results of Prior et al. (13) . However, urinary xantho-pterin levels were elevated in patients with chronic non-A, non-B hepatitis and in those with fatty liver disease. Biopterin levels did not differ significantly between healthy individuals and patients with either chronic non-A, non-B hepatitis or fatty liver. In this study, The relative and absolute frequency of patients having a measured value greater than the mean + 2SD of normal controls are shown. neopterin and biopterin were assayed by HPLC using oxidized urine.
After our preliminary study, we assayed urinary neopterin and xanthopterin levels in different types of liver disease (25) . Neopterin levels were assayed by using RIA without oxidation. In this study, 67-88% of patients with acute hepatitis, chronic active hepatitis, liver cirrhosis or alcoholinduced liver disease showed abnormal xanthopterin values. However, 25-31% of patients with chronic persistent hepatitis and non-alcoholic fatty liver showed abnormal values. On the contrary, 62-100% of patients with acute hepatitis, chronic active hepatitis, chronic persistent hepatitis or liver cirrhosis showed abnormal neopterin values, while 22-33% of patients with alcohol-induced or non-alcoholic fatty liver showed abnormal values (Table 1 ). These data show that urinary neopterin levels are high in the setting of infectious diseases characterized by activated cellmediated immunity, and that increased urinary xanthopterin levels reflect liver-cell damage rather than the hyperimmune state.
Plasma neopterin and anti-Hey -positive donors
In 1989, Chiron Corporation established screening methods for hepatitis C virus (HCV) (26, 27 ) . After the introduction of the anti-HCV antibody (anti-HCV) screening test in blood centPteridines/ Vol. 7 / No. 4 ers in Japan, the incidence of post-transfusion hepatitis decreased dramatically (14) (15) (16) . We therefore retrospectively assayed plasma neopterin levels in two groups, i.e., anti-HCV-positive and HCV-negative donors with elevated ALT, and attempted to correlated the neopterin values with anti-HCV positivity, then we compared these results to those of normal control donors (28) . Plasma neopterin levels were assayed by RIA without oxidation, and 35% of anti-HCVpositive donors with elevated ALT were shown to have abnormal neopterin levels while anti-HCV-negative donors with elevated ALT had the same levels as healthy subjects (Table 2) . These results show that plasma neopterin assay is a useful alternative test for prevention of PTHNANB. At present, the usefulness of ALT for blood donor screening is in some doubt. Currently, over 3% of donations to blood centers in Japan are discarded due to elevated ALT levels. Based on our results, anti-HCV-negative donors with elevated AL T are not in a hyperimmune state. The ALT elevations in anti-HCV-negative donors are considered to be attributable mainly to steatosis due to excess body weight and/or alcohol consumption.
Detection of malignant disease in the early stage
In the course of our study on the determination ..: were 899 ~moVmol creatinine and 577 ~moVmol creatinine, respectively. Urinary neopterin were assayed using HPLC after iodine oxidation.
of urinary pteridines for use as a clinical marker in liver disease, one of the authors (M.T.) incidentally found his urinary pteridine level to be higher than the normal maximum although he felt healthy. At that time, general tumor indicators such as CEA, SCC and Ca19-9 were all within normal range. However, endoscopic examination revealed an abnormality in the squamous epithelium of his esophagus. A biopsy revealed the presence of well differentiated squamous cell carcinoma. Postoperatively, we found that the squamous cell carcinoma measured 1.5 x 1.2 cm and did not stain with Lugol's solution. On histological observation, the nucleolus was clear. We compared longitudinal changes in his urinary excretion levels of xanthopterin and neopterin before and after surgery (Figure 1 ). Both urinary xanthopterin and neopterin showed dramatic changes during hospitalization. The levels of these pteridines were extremely high values just before and after surgery, then gradually diminished reaching normal values within a few months. This remarkable case suggests that determination of urinary neopterin levels may be a sensitive and valuable indicator of malignant disease in the future (29) .
Discussion
Wachter et al. first found that levels of urinary neopterin rose in patients with viral and malignant diseases (30 ) . Later, several reports showed that in organ transplantation recipients distinct increases in neopterin levels accompanied both rejections and infections (31) (32) (33) (34) . Furthermore, neopterin is a sensitive marker of HIV infection and reportedly increases 2 weeks before HIV infection can be detected using antibodies (35 ) . Progressive infection is paralleled by further elevation of neopterin levels (36) (37) (38) . Neopterin levels rise in the setting of infectious or malignant disorders characterized by activated cell-mediated immunity (10) (11) (12) . Neopterin is produced mainly in human monocytes/macrophages, and its release is accelerated by stimulation with interferon-y (39-41). Serum neopterin levels also rise after interferon-a. treatment in patients with chronic hepatitis type C [Fukuda A: personal communication).
Our studies also indicate that both urinary and plasma pteridine levels are useful as clinical indicators. After the introduction of anti-HCV screening, the incidence of post-transfusion non-B, non-C hepatitis reportedly decreased to approximately 0.48% among patients who received transfusion therapy (42) . Whether or not such infections are due to real post-transfusion viral infection, new possible hepatitis viruses have been reported (43, 44) . Transfusion transmitted disease is attributable to unscreenable viruses and/or the window period of viral infection. The measurement of plasma and urinary neopterin levels can be used for screening blood donors who have activated cell-mediated immunity produced by an unknown viral infection. Although plasma and urinary neopterin levels are excellent markers, practical applications are not widespread. When the assay method for plasma and urinary neopterin levels has been simplified, and made more sensitive and reproducible, these measurements will serve as valuable and important clinical indicators.
